We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
+57.97%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$1.28B
AUM Growth
+$424M
Cap. Flow
+$743K
Cap. Flow %
0.06%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$2.71M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$1.97M

Sector Composition

Rank Sector Weight
1 Healthcare 56.68%
2 Consumer Staples 25.23%
3 Industrials 5.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.21B
$665M 51.95%
10,799,410
– –
MNST icon
2
Monster Beverage
MNST
$94.3B
$323M 25.23%
9,312,976
– –
IWM icon
3
iShares Russell 2000 ETF
IWM
$79.8B
$157M 12.26%
1,095,000
-15,000
-1% -$1.97M
AXON
4
Axon Enterprise
AXON
$42.5B
$74.6M 5.83%
760,062
– –
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$269M
$29.6M 2.31%
34,005,379
– –
IMDX
6
Insight Molecular Diagnostics
IMDX
$150M
$28.1M 2.2%
735,810
+52,500
+8% +$2.71M
SER icon
7
Serina Therapeutics
SER
$30M
$2.84M 0.22%
85,219
– –

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Broadwood Capital held 7 positions worth $1.28B, up 50% from $856M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2020: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 48% a quarter earlier, followed by Consumer Staples and Industrials.

  • Broadwood Capital added most to Insight Molecular Diagnostics in Q2 2020, an estimated $2.71M increase.
  • Broadwood Capital's biggest Q2 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $1.97M.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.28B portfolio in Q2 2020.
  • Broadwood Capital opened 0 new positions and closed 0 in Q2 2020.
  • Broadwood Capital's portfolio value rose 50% quarter-over-quarter to $1.28B.

Based on Broadwood Capital's 13F filing for Q2 2020, filed 14 Aug 2020.